Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiaeScott B. Ficarro, Forest M. White, Mark L. McCleland et al.|Nature Biotechnology|2002Cited by 1.6k
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialEnriqueta Felip, Heather A. Wakelee, Nasser K. Altorki et al.|The Lancet|2021Cited by 1.5k
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V. Liu, Leora Horn, Francesco Orlandi et al.|Journal of Clinical Oncology|2021Cited by 818
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancerMark L. McCleland, Ron Firestein|Journal of Clinical Investigation|2016Cited by 230
IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC).Heather A. Wakelee, Enriqueta Felip, Nasser K. Altorki et al.|Journal of Clinical Oncology|2021Cited by 117